Free Trial
→ Market Crash Warning: How to Protect Your Wealth Before August 12th (From American Alternative) (Ad) Free EFX Stock Alerts

Equifax (EFX) Financials

Equifax logo
$239.61 -0.62 (-0.26%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$242.21 +2.60 (+1.09%)
As of 08/1/2025 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Equifax

Annual Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 429 489 587 311 -384 520 744 696 545 604
Consolidated Net Income / (Loss)		 435 495 598 317 -378 526 749 700 552 607
Net Income / (Loss) Continuing Operations		 435 495 598 317 -378 526 749 700 552 607
Total Pre-Tax Income 		637 728 747 370 -414 685 949 930 718 811
Total Revenue		 2,600 -92 3,269 3,309 3,396 -142 4,778 4,939 5,024 5,452
Net Interest Income / (Expense)		 -64 -92 -93 -104 -112 -142 -146 -183 -241 -229
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 64 92 93 104 112 142 146 183 241 229
Long-Term Debt Interest Expense		 64 92 93 104 112 142 146 183 241 229
Total Non-Interest Income		 2,664 0.00 3,362 3,412 3,508 0.00 4,924 5,122 5,265 5,681
Other Non-Interest Income		 2,664 - 3,362 3,412 3,508 - 4,924 5,122 5,265 5,681
Total Non-Interest Expense		 1,970 -820 2,531 2,964 3,843 -827 3,786 4,066 4,332 4,639
Property & Liability Insurance Claims		 - - 1,211 - 1,522 - 1,981 2,177 2,335 2,519
Other Operating Expenses		 1,772 2,054 1,032 2,654 1,990 3,060 1,325 1,329 1,386 1,451
Depreciation Expense		 198 265 288 310 331 391 480 560 611 670
Nonoperating Income / (Expense), net		 6.50 - 7.70 26 33 - -43 57 26 -2.50
Income Tax Expense		 202 233 149 53 -36 159 201 230 166 203
Net Income / (Loss) Attributable to Noncontrolling Interest		 5.70 6.30 11 6.50 6.00 6.10 4.30 4.00 6.40 3.20
Basic Earnings per Share		 $3.61 $4.10 $4.89 $2.58 ($3.18) $4.28 $6.11 $5.69 $4.44 $4.88
Weighted Average Basic Shares Outstanding		 118.70M 119.30M 120.10M 120.40M 120.90M 121.50M 121.90M 122.40M 122.90M 123.80M
Diluted Earnings per Share		 $3.55 $4.04 $4.83 $2.56 ($3.15) $4.24 $6.02 $5.65 $4.40 $4.84
Weighted Average Diluted Shares Outstanding		 120.90M 121.10M 121.50M 121.40M 122M 122.80M 123.60M 123.30M 123.90M 124.90M
Weighted Average Basic & Diluted Shares Outstanding		 118.90M 119.20M 120.10M 120.40M 120.80M 121.79M 122.08M 122.49M 123.96M 124.02M
Cash Dividends to Common per Share		 $1.16 $1.32 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56

Quarterly Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 166 108 112 138 162 132 125 164 141 174 133
Consolidated Net Income / (Loss)		 167 109 114 139 164 135 126 165 143 173 134
Net Income / (Loss) Continuing Operations		 167 109 114 139 164 135 126 165 143 173 134
Total Pre-Tax Income 		220 141 152 192 191 183 167 225 194 226 185
Total Revenue		 1,197 1,143 1,244 1,257 1,256 1,266 1,330 1,373 1,386 1,364 1,389
Net Interest Income / (Expense)		 -47 -55 -58 -61 -63 -60 -60 -57 -56 -56 -53
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 47 55 58 61 63 60 60 57 56 56 53
Long-Term Debt Interest Expense		 47 55 58 61 63 60 60 57 56 56 53
Total Non-Interest Income		 1,244 1,198 1,302 1,318 1,319 1,327 1,389 1,431 1,442 1,419 1,442
Other Non-Interest Income		 1,244 1,198 1,302 1,318 1,319 1,327 1,389 1,431 1,442 1,419 1,442
Total Non-Interest Expense		 1,001 1,022 1,097 1,081 1,073 1,082 1,165 1,148 1,195 1,131 1,206
Property & Liability Insurance Claims		 543 539 580 - 585 - 628 - 645 - 657
Other Operating Expenses		 318 340 366 931 333 -245 373 984 380 -286 375
Depreciation Expense		 141 142 150 150 154 157 164 165 169 172 175
Nonoperating Income / (Expense), net		 24 20 4.40 16 7.10 -1.70 1.60 -0.30 3.00 -6.80 2.50
Income Tax Expense		 53 32 39 53 26 48 41 59 51 52 52
Net Income / (Loss) Attributable to Noncontrolling Interest		 1.20 1.00 1.10 1.10 2.10 2.10 1.20 1.30 1.40 -0.70 0.70
Basic Earnings per Share		 $1.35 $0.88 $0.92 $1.13 $1.32 $1.07 $1.01 $1.32 $1.14 $1.41 $1.07
Weighted Average Basic Shares Outstanding		 122.40M 122.40M 122.60M 122.70M 123M 122.90M 123.50M 123.70M 123.90M 123.80M 124.10M
Diluted Earnings per Share		 $1.34 $0.88 $0.91 $1.12 $1.31 $1.06 $1.00 $1.31 $1.13 $1.40 $1.06
Weighted Average Diluted Shares Outstanding		 123.30M 123.30M 123.50M 123.80M 123.90M 123.90M 124.80M 124.80M 125.20M 124.90M 125.10M
Weighted Average Basic & Diluted Shares Outstanding		 122.44M 122.49M 122.64M 122.72M 123.22M 123.96M 123.61M 123.74M 123.95M 124.02M 124.20M
Cash Dividends to Common per Share		 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39

Annual Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -35 36 207 -113 178 1,283 -1,460 61 -68 -47
Net Cash From Operating Activities		 769 823 816 672 314 946 1,335 757 1,117 1,325
Net Cash From Continuing Operating Activities		 769 823 816 672 314 946 1,335 757 1,123 1,325
Net Income / (Loss) Continuing Operations		 435 495 598 317 -378 526 749 700 552 607
Consolidated Net Income / (Loss)		 435 495 598 317 -378 526 749 700 552 607
Depreciation Expense		 200 269 291 316 337 399 490 569 620 681
Non-Cash Adjustments to Reconcile Net Income		 -5.50 -12 -5.80 43 -33 -28 123 114 -12 15
Changes in Operating Assets and Liabilities, net		 140 71 -67 -3.20 388 49 -26 -626 -36 22
Net Cash From Investing Activities		 -148 -1,976 -350 -462 -698 -493 -3,398 -960 -878 -512
Net Cash From Continuing Investing Activities		 -148 -1,976 -350 -462 -698 -493 -3,398 -960 -878 -512
Purchase of Investment Securities		 -151 -1,976 -358 -6.90 -698 -493 -3,405 -1,058 -284 -512
Divestitures		 2.90 - - - 0.00 0.00 1.50 99 6.90 0.00
Net Cash From Financing Activities		 -639 1,160 -264 -311 558 811 618 274 -306 -846
Net Cash From Continuing Financing Activities		 -639 1,160 -264 -311 558 811 618 274 -306 -846
Issuance of Debt		 0.00 1,575 352 995 998 1,123 1,697 992 873 650
Repayment of Debt		 -336 -283 -323 -1,067 -257 -136 -791 -506 -957 -1,360
Payment of Dividends		 -144 -163 -196 -198 -195 -194 -197 -194 -237 -198
Other Financing Activities, Net		 37 32 -20 -40 12 17 -22 -17 15 61
Effect of Exchange Rate Changes		 -17 29 4.30 -13 3.50 19 -14 -11 -0.80 -14

Quarterly Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 18 44 -53 -68 249 -196 -16 -19 286 -298 25
Net Cash From Operating Activities		 355 325 151 262 382 322 253 268 480 325 224
Net Cash From Continuing Operating Activities		 355 325 151 262 382 328 253 268 480 325 224
Net Income / (Loss) Continuing Operations		 167 109 114 139 164 135 126 165 143 173 134
Consolidated Net Income / (Loss)		 167 109 114 139 164 135 126 165 143 173 134
Depreciation Expense		 143 145 152 152 157 159 167 167 173 174 176
Non-Cash Adjustments to Reconcile Net Income		 17 36 25 8.30 -53 8.20 23 -2.60 6.00 -12 31
Changes in Operating Assets and Liabilities, net		 28 36 -140 -38 114 27 -63 -62 157 -10 -117
Net Cash From Investing Activities		 -478 -152 -163 -156 -406 -154 -132 -137 -124 -119 -107
Net Cash From Continuing Investing Activities		 -478 -152 -163 -156 -406 -154 -132 -137 -124 -119 -107
Purchase of Investment Securities		 -479 -152 -163 -163 -406 448 -132 -137 -124 -119 -107
Net Cash From Financing Activities		 152 -143 -43 -174 281 -370 -132 -149 -64 -501 -96
Net Cash From Continuing Financing Activities		 152 -143 -43 -174 281 -370 -132 -149 -64 -501 -96
Repayment of Debt		 -5.40 -501 -161 -831 327 -292 -88 -115 -694 -463 -48
Payment of Dividends		 -48 -48 -48 -50 -49 -91 -49 -51 -49 -49 -49
Other Financing Activities, Net		 -0.70 16 -9.30 8.90 2.10 13 4.50 18 29 10 0.80
Effect of Exchange Rate Changes		 -9.90 13 2.30 -0.50 -7.90 5.30 -4.70 -1.10 -4.90 -2.80 4.40

Annual Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 4,502 6,664 7,233 7,153 7,909 9,612 11,041 11,548 12,280 11,759
Cash and Due from Banks		 93 129 336 224 401 1,685 225 285 217 170
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 154 160 139 81 948 -235 1,316 1,587 1,834 1,892
Goodwill		 2,571 3,974 4,184 4,130 4,308 4,496 6,258 6,384 6,830 6,548
Intangible Assets		 1,135 1,726 1,770 1,878 1,140 2,467 1,993 1,913 1,954 1,616
Other Assets		 548 675 804 841 1,112 1,199 1,249 1,379 1,446 1,534
Total Liabilities & Shareholders' Equity		 4,502 6,664 7,233 7,153 7,909 9,612 11,041 11,548 12,280 11,759
Total Liabilities		 2,151 3,943 3,994 3,998 5,286 6,402 7,440 7,575 7,593 6,840
Short-Term Debt		 90 666 1,076 181 151 1,260 1,036 1,218 1,161 826
Accrued Interest Payable		 113 149 161 213 164 252 238 229 245 251
Other Short-Term Payables		 401 444 329 433 1,044 971 1,017 568 613 735
Long-Term Debt		 1,138 2,087 1,739 2,631 3,380 3,277 4,470 4,820 4,748 4,323
Other Long-Term Liabilities		 409 596 690 540 548 641 678 739 826 706
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - - - 0.00 135 105
Total Equity & Noncontrolling Interests		 2,350 2,721 3,239 3,156 2,623 3,210 3,601 3,973 4,552 4,814
Total Preferred & Common Equity		 2,311 2,663 3,174 3,108 2,579 3,168 3,584 3,957 4,534 4,797
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2,311 2,663 3,174 3,108 2,579 3,168 3,584 3,957 4,534 4,797
Common Stock		 1,491 1,544 1,563 1,587 1,636 1,701 1,767 1,825 1,992 2,146
Retained Earnings		 3,834 4,153 4,601 4,718 3,855 4,185 4,752 5,256 5,609 6,019
Treasury Stock		 -2,530 -2,506 -2,578 -2,571 -2,557 -2,547 -2,639 -2,651 -2,635 -2,645
Accumulated Other Comprehensive Income / (Loss)		 -485 -529 -412 -626 -354 -171 -295 -474 -431 -723
Noncontrolling Interest		 40 59 65 48 44 42 17 17 18 18

Quarterly Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Total Assets		 11,308 11,548 11,584 11,538 12,349 12,280 12,251 12,152 12,344 11,759 11,855
Cash and Due from Banks		 242 285 233 164 413 217 201 182 468 170 195
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 -498 1,587 -570 -629 -665 1,834 -746 -813 -874 1,892 -974
Goodwill		 6,304 6,384 6,396 6,401 6,731 6,830 6,761 6,747 6,730 6,548 6,591
Intangible Assets		 3,938 1,913 4,080 4,145 4,427 1,954 4,464 4,483 4,517 1,616 4,432
Other Assets		 1,323 1,379 1,446 1,457 1,443 1,446 1,571 1,554 1,503 1,534 1,611
Total Liabilities & Shareholders' Equity		 11,308 11,548 11,584 11,538 12,349 12,280 12,251 12,152 12,344 11,759 11,855
Total Liabilities		 7,532 7,575 7,502 7,330 7,864 7,593 7,539 7,319 7,298 6,840 6,742
Short-Term Debt		 1,236 1,218 962 317 692 1,161 1,078 972 903 826 812
Accrued Interest Payable		 222 229 283 271 267 245 306 238 263 251 281
Other Short-Term Payables		 561 568 548 504 623 613 590 577 708 735 638
Long-Term Debt		 4,819 4,820 4,988 5,503 5,500 4,748 4,745 4,743 4,721 4,323 4,324
Other Long-Term Liabilities		 695 739 722 734 782 826 820 789 702 706 687
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - 0.00 - - 176 135 132 121 121 105 113
Total Equity & Noncontrolling Interests		 3,776 3,973 4,082 4,208 4,309 4,552 4,581 4,713 4,926 4,814 5,000
Total Preferred & Common Equity		 3,759 3,957 4,064 4,191 4,293 4,534 4,562 4,696 4,909 4,797 4,981
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 3,759 3,957 4,064 4,191 4,293 4,534 4,562 4,696 4,909 4,797 4,981
Common Stock		 1,811 1,825 1,862 1,881 1,967 1,992 2,055 2,088 2,128 2,146 2,184
Retained Earnings		 5,196 5,256 5,320 5,411 5,525 5,609 5,685 5,800 5,893 6,019 6,103
Treasury Stock		 -2,651 -2,651 -2,657 -2,655 -2,635 -2,635 -2,652 -2,648 -2,647 -2,645 -2,648
Accumulated Other Comprehensive Income / (Loss)		 -596 -474 -461 -446 -564 -431 -527 -544 -465 -723 -657
Noncontrolling Interest		 17 17 18 17 16 18 19 17 17 18 19

Annual Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 9.80% -103.54% 3,649.84% 1.20% 2.64% -104.17% 3,474.51% 3.37% 1.71% 8.52%
EBITDA Growth		 7.28% 20.09% 3.30% -35.87% -116.63% 1,087.70% 36.65% -2.73% -8.99% 13.84%
EBIT Growth		 10.62% 15.57% 1.47% -53.38% -229.78% 253.25% 44.83% -12.03% -20.71% 17.45%
NOPAT Growth		 16.00% 15.04% 19.54% -50.18% -206.15% 268.13% 48.72% -15.98% -19.09% 14.52%
Net Income Growth		 16.26% 13.87% 20.78% -46.99% -219.27% 239.17% 42.25% -6.45% -21.21% 10.08%
EPS Growth		 19.53% 13.80% 19.55% -47.00% -223.05% 234.60% 41.98% -6.15% -22.12% 10.00%
Operating Cash Flow Growth		 24.81% 7.01% -0.85% -17.62% -53.32% 201.53% 41.07% -43.28% 47.51% 18.60%
Free Cash Flow Firm Growth		 61.02% -321.40% 100.91% 2,896.52% -231.02% -113.62% 45.93% 57.36% 78.49% 2,247.63%
Invested Capital Growth		 -5.35% 52.97% 10.58% -1.43% 3.13% 25.90% 17.55% 9.92% 5.84% -4.98%
Revenue Q/Q Growth		 1.67% -103.15% 303.60% -33.92% 2.03% -103.75% 822.99% -1.42% 2.51% 1.82%
EBITDA Q/Q Growth		 1.59% 4.75% -1.14% -17.89% 5.18% 34.92% -2.53% -5.41% 6.27% 4.37%
EBIT Q/Q Growth		 2.34% 3.04% -1.70% -30.38% -0.43% 63.10% -6.51% -9.55% 10.03% 6.23%
NOPAT Q/Q Growth		 2.32% 2.44% 7.94% -33.90% -0.43% 67.54% 11.30% -11.63% 8.67% 7.52%
Net Income Q/Q Growth		 3.38% 2.44% 9.06% -30.18% -3.28% 11.01% 6.46% -1.96% 4.83% 6.83%
EPS Q/Q Growth		 3.50% 2.54% 9.03% -30.43% -2.94% 10.42% 6.55% -1.74% 4.27% 7.56%
Operating Cash Flow Q/Q Growth		 3.99% 5.99% -8.06% -5.95% 26.58% 7.56% 7.07% -7.33% -0.29% 0.20%
Free Cash Flow Firm Q/Q Growth		 -14.24% 9.60% -95.28% -1.45% -150.89% 17.12% 42.88% -287.90% 85.15% 98.71%
Invested Capital Q/Q Growth		 -1.78% -3.56% 1.66% -0.78% 4.28% 3.25% -1.19% 1.84% -0.75% -5.65%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 31.93% 0.00% 31.50% 19.96% -3.23% 0.00% 31.02% 29.19% 26.12% 27.40%
EBIT Margin		 24.24% 0.00% 22.60% 10.41% -13.17% 0.00% 20.77% 17.67% 13.78% 14.91%
Profit (Net Income) Margin		 16.72% 0.00% 18.29% 9.58% -11.13% 0.00% 15.66% 14.18% 10.98% 11.14%
Tax Burden Percent		 68.30% 67.99% 80.10% 85.58% 91.37% 76.80% 78.86% 75.31% 76.85% 74.93%
Interest Burden Percent		 101.03% 100.00% 101.04% 107.52% 92.55% 100.00% 95.65% 106.49% 103.71% 99.69%
Effective Tax Rate		 31.70% 32.01% 19.90% 14.42% 0.00% 23.20% 21.14% 24.69% 23.15% 25.07%
Return on Invested Capital (ROIC)		 11.70% 0.00% 10.27% 4.91% -5.16% 0.00% 9.29% 6.88% 5.16% 5.90%
ROIC Less NNEP Spread (ROIC-NNEP)		 12.02% 0.00% 10.49% 5.69% -7.22% 0.00% 8.61% 7.62% 5.49% 5.86%
Return on Net Nonoperating Assets (RNNOA)		 7.27% 0.00% 9.80% 5.01% -7.92% 0.00% 12.69% 11.61% 7.58% 6.75%
Return on Equity (ROE)		 18.97% 19.52% 20.07% 9.91% -13.09% 18.04% 21.98% 18.49% 12.74% 12.64%
Cash Return on Invested Capital (CROIC)		 17.19% -30.94% 0.22% 6.35% -8.25% -15.36% -6.85% -2.58% -0.51% 11.01%
Operating Return on Assets (OROA)		 13.75% 0.00% 10.63% 4.79% -5.94% 0.00% 9.61% 7.73% 5.81% 6.76%
Return on Assets (ROA)		 9.49% 0.00% 8.61% 4.41% -5.02% 0.00% 7.25% 6.20% 4.63% 5.05%
Return on Common Equity (ROCE)		 18.66% 19.15% 19.65% 9.74% -12.88% 17.77% 21.79% 18.41% 12.49% 12.28%
Return on Equity Simple (ROE_SIMPLE)		 18.82% 18.59% 18.84% 10.20% -14.66% 16.61% 20.88% 17.70% 12.17% 12.66%
Net Operating Profit after Tax (NOPAT)		 430 495 592 295 -313 526 783 657 532 609
NOPAT Margin		 16.55% 0.00% 18.10% 8.91% -9.22% 0.00% 16.38% 13.31% 10.59% 11.17%
Net Nonoperating Expense Percent (NNEP)		 -0.32% 0.00% -0.22% -0.79% 2.05% 0.00% 0.68% -0.74% -0.33% 0.03%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 75.76% 0.00% 77.40% 89.59% 113.17% 0.00% 79.23% 82.33% 86.22% 85.09%
Earnings before Interest and Taxes (EBIT)		 630 728 739 345 -447 685 992 873 692 813
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 830 997 1,030 660 -110 1,085 1,482 1,442 1,312 1,494
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 5.25 4.94 4.20 3.45 6.35 7.22 9.78 5.93 6.68 6.59
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 4.67 0.00 4.08 3.24 4.82 0.00 7.34 4.75 6.03 5.79
Price to Earnings (P/E)		 28.28 26.94 22.69 34.50 0.00 43.98 47.12 33.73 55.55 52.29
Dividend Yield		 1.13% 1.20% 1.41% 1.76% 1.15% 0.83% 0.54% 0.81% 0.63% 0.61%
Earnings Yield		 3.54% 3.71% 4.41% 2.90% 0.00% 2.27% 2.12% 2.96% 1.80% 1.91%
Enterprise Value to Invested Capital (EV/IC)		 3.72 2.90 2.62 2.24 3.18 3.33 4.43 2.92 3.41 3.64
Enterprise Value to Revenue (EV/Rev)		 5.12 0.00 4.85 4.03 5.76 0.00 8.45 5.92 7.19 6.73
Enterprise Value to EBITDA (EV/EBITDA)		 16.03 15.90 15.41 20.21 0.00 23.76 27.24 20.29 27.54 24.57
Enterprise Value to EBIT (EV/EBIT)		 21.12 21.76 21.48 38.74 0.00 37.61 40.68 33.51 52.20 45.13
Enterprise Value to NOPAT (EV/NOPAT)		 30.92 32.01 26.81 45.27 0.00 48.98 51.58 44.49 67.93 60.23
Enterprise Value to Operating Cash Flow (EV/OCF)		 17.30 19.26 19.45 19.85 62.32 27.24 30.24 38.64 32.36 27.70
Enterprise Value to Free Cash Flow (EV/FCFF)		 21.03 0.00 1,246.36 34.98 0.00 0.00 0.00 0.00 0.00 32.26
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.52 1.01 0.87 0.89 1.35 1.41 1.53 1.52 1.26 1.05
Long-Term Debt to Equity		 0.48 0.77 0.54 0.83 1.29 1.02 1.24 1.21 1.01 0.88
Financial Leverage		 0.61 0.79 0.93 0.88 1.10 1.38 1.47 1.52 1.38 1.15
Leverage Ratio		 2.00 2.20 2.33 2.25 2.61 3.00 3.03 2.98 2.75 2.50
Compound Leverage Factor		 2.02 2.20 2.36 2.42 2.41 3.00 2.90 3.18 2.85 2.49
Debt to Total Capital		 34.32% 50.29% 46.49% 47.11% 57.38% 58.57% 60.46% 60.31% 55.76% 51.14%
Short-Term Debt to Total Capital		 2.51% 12.17% 17.77% 3.03% 2.46% 16.27% 11.38% 12.17% 10.96% 8.20%
Long-Term Debt to Total Capital		 31.81% 38.12% 28.73% 44.09% 54.92% 42.30% 49.08% 48.15% 44.81% 42.93%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.10% 1.07% 1.07% 0.80% 0.72% 0.54% 0.18% 0.17% 1.45% 1.22%
Common Equity to Total Capital		 64.57% 48.64% 52.44% 52.08% 41.90% 40.89% 39.36% 39.52% 42.79% 47.64%
Debt to EBITDA		 1.48 2.76 2.73 4.26 -32.16 4.18 3.72 4.19 4.50 3.45
Net Debt to EBITDA		 1.37 2.63 2.41 3.92 -28.50 2.63 3.56 3.99 4.34 3.33
Long-Term Debt to EBITDA		 1.37 2.09 1.69 3.98 -30.78 3.02 3.02 3.34 3.62 2.89
Debt to NOPAT		 2.85 5.56 4.76 9.53 -11.28 8.62 7.04 9.18 11.11 8.45
Net Debt to NOPAT		 2.64 5.30 4.19 8.78 -10.00 5.42 6.75 8.75 10.70 8.17
Long-Term Debt to NOPAT		 2.65 4.21 2.94 8.92 -10.80 6.23 5.71 7.33 8.93 7.10
Noncontrolling Interest Sharing Ratio		 1.61% 1.93% 2.07% 1.76% 1.60% 1.48% 0.86% 0.44% 1.97% 2.87%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 633 -1,401 13 382 -500 -1,068 -577 -246 -53 1,137
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 208.82% 0.00% 0.00% 0.00% 0.00% 185.73% 0.00%
Free Cash Flow to Firm to Interest Expense		 9.92 -15.21 0.14 3.69 -4.48 -7.54 -3.97 -1.35 -0.22 4.96
Operating Cash Flow to Interest Expense		 12.05 8.94 8.79 6.49 2.81 6.68 9.17 4.14 4.63 5.78
Operating Cash Flow Less CapEx to Interest Expense		 12.05 8.94 8.79 3.38 2.81 6.68 9.17 4.14 2.14 5.78
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.57 0.00 0.47 0.46 0.45 0.00 0.46 0.44 0.42 0.45
Fixed Asset Turnover		 26.31 0.00 21.87 30.11 6.60 0.00 0.00 3.40 2.94 2.93
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 3,579 5,475 6,054 5,967 6,154 7,748 9,108 10,011 10,596 10,068
Invested Capital Turnover		 0.71 0.00 0.57 0.55 0.56 0.00 0.57 0.52 0.49 0.53
Increase / (Decrease) in Invested Capital		 -202 1,896 579 -87 187 1,594 1,360 904 585 -528
Enterprise Value (EV)		 13,308 15,848 15,869 13,346 19,556 25,771 40,367 29,251 36,135 36,691
Market Capitalization		 12,133 13,166 13,327 10,711 16,383 22,877 35,068 23,481 30,290 31,589
Book Value per Share		 $19.51 $22.23 $26.44 $25.77 $21.30 $26.05 $29.38 $32.31 $36.80 $38.70
Tangible Book Value per Share		 ($11.78) ($25.36) ($23.15) ($24.05) ($23.70) ($31.19) ($38.25) ($35.45) ($34.49) ($27.16)
Total Capital		 3,579 5,475 6,054 5,967 6,154 7,748 9,108 10,011 10,596 10,068
Total Debt		 1,228 2,753 2,815 2,811 3,531 4,538 5,507 6,038 5,909 5,149
Total Long-Term Debt		 1,138 2,087 1,739 2,631 3,380 3,277 4,470 4,820 4,748 4,323
Net Debt		 1,135 2,624 2,478 2,588 3,130 2,853 5,282 5,753 5,692 4,979
Capital Expenditures (CapEx)		 0.00 0.00 0.00 322 0.00 0.00 0.00 0.00 601 0.00
Net Nonoperating Expense (NNE)		 -4.44 0.00 -6.17 -22 65 0.00 34 -43 -20 1.87
Net Nonoperating Obligations (NNO)		 1,228 2,753 2,815 2,811 3,531 4,538 5,507 6,038 5,909 5,149
Total Depreciation and Amortization (D&A)		 200 269 291 316 337 399 490 569 620 681
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.61 $4.10 $4.89 $2.49 ($3.30) $4.28 $6.11 $5.69 $4.44 $4.88
Adjusted Weighted Average Basic Shares Outstanding		 118.70M 119.30M 120.10M 120.40M 120.90M 121.50M 121.90M 122.40M 122.90M 123.80M
Adjusted Diluted Earnings per Share		 $3.55 $4.04 $4.83 $2.47 ($3.27) $4.24 $6.02 $5.65 $4.40 $4.84
Adjusted Weighted Average Diluted Shares Outstanding		 120.90M 121.10M 121.50M 121.40M 122M 122.80M 123.60M 123.30M 123.90M 124.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($3.30) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 118.71M 119.85M 120.12M 120.70M 121.24M 121.79M 122.08M 122.49M 123.96M 124.02M
Normalized Net Operating Profit after Tax (NOPAT)		 430 -1,640 592 295 -313 -2,759 783 657 532 609
Normalized NOPAT Margin		 16.55% 0.00% 18.10% 8.91% -9.22% 0.00% 16.38% 13.31% 10.59% 11.17%
Pre Tax Income Margin		 24.49% 0.00% 22.84% 11.20% -12.19% 0.00% 19.86% 18.82% 14.29% 14.87%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 9.88 7.91 7.96 3.33 -4.00 4.84 6.82 4.77 2.87 3.55
NOPAT to Interest Expense		 6.75 5.38 6.38 2.85 -2.80 3.72 5.37 3.59 2.20 2.66
EBIT Less CapEx to Interest Expense		 9.88 7.91 7.96 0.22 -4.00 4.84 6.82 4.77 0.38 3.55
NOPAT Less CapEx to Interest Expense		 6.75 5.38 6.38 -0.26 -2.80 3.72 5.37 3.59 -0.29 2.66
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 33.16% 33.00% 32.74% 62.52% -51.65% 36.89% 26.25% 27.73% 43.03% 32.57%
Augmented Payout Ratio		 78.31% 33.00% 45.64% 62.52% -51.65% 36.89% 35.59% 27.73% 43.03% 32.57%

Quarterly Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.78% -5.87% -5.98% -1.43% 4.94% 10.74% 6.85% 9.25% 10.28% 7.69% 4.47%
EBITDA Growth		 -5.05% -23.65% -30.56% -18.92% 0.47% 29.10% 10.53% 19.34% 7.02% 18.23% 8.35%
EBIT Growth		 -17.80% -43.14% -49.50% -33.00% -6.23% 51.93% 11.64% 27.64% 3.92% 25.84% 10.85%
NOPAT Growth		 -19.78% -50.75% -48.65% -36.08% 6.35% 44.81% 13.31% 29.37% -11.18% 31.51% 5.69%
Net Income Growth		 -19.22% -11.37% -49.06% -30.78% -1.56% 23.28% 11.10% 18.51% -13.15% 28.85% 6.11%
EPS Growth		 -19.28% -10.20% -49.44% -31.29% -2.24% 20.45% 9.89% 16.96% -13.74% 32.08% 6.00%
Operating Cash Flow Growth		 -10.92% -15.55% 176.02% -4.79% 7.55% -1.01% 67.46% 2.06% 25.62% 0.84% -11.40%
Free Cash Flow Firm Growth		 69.63% 30.75% 96.00% 89.50% -48.18% 44.55% -448.00% -73.17% 121.25% 257.30% 210.44%
Invested Capital Growth		 6.65% 9.92% 1.82% 3.42% 8.61% 5.84% 5.02% 5.18% -0.05% -4.98% -2.72%
Revenue Q/Q Growth		 -6.11% -4.49% 8.83% 1.00% -0.05% 0.79% 5.02% 3.27% 0.90% -1.58% 1.87%
EBITDA Q/Q Growth		 -16.35% -21.46% 12.78% 9.43% 3.66% 0.91% -3.44% 18.15% -7.04% 11.48% -11.50%
EBIT Q/Q Growth		 -25.55% -37.95% 21.65% 19.22% 4.20% 0.54% -10.62% 36.30% -15.16% 21.75% -21.27%
NOPAT Q/Q Growth		 -25.64% -36.98% 17.57% 16.01% 23.71% -14.18% -8.00% 32.45% -15.07% 27.07% -26.06%
Net Income Q/Q Growth		 -17.13% -34.63% 4.03% 22.82% 17.86% -18.14% -6.25% 31.01% -13.62% 21.44% -22.79%
EPS Q/Q Growth		 -17.79% -34.33% 3.41% 23.08% 16.96% -19.08% -5.66% 31.00% -13.74% 23.89% -24.29%
Operating Cash Flow Q/Q Growth		 28.91% -8.31% -53.63% 73.69% 45.63% -15.61% -21.55% 5.86% 79.25% -32.26% -31.07%
Free Cash Flow Firm Q/Q Growth		 76.13% -74.46% 91.46% -195.22% -236.82% 34.71% 15.59% 6.71% 141.33% 383.29% -40.74%
Invested Capital Q/Q Growth		 1.38% 1.84% 0.20% -0.03% 6.46% -0.75% -0.57% 0.12% 1.17% -5.65% 1.79%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 28.29% 23.26% 24.11% 26.12% 27.09% 27.12% 24.94% 28.53% 26.29% 29.77% 25.87%
EBIT Margin		 16.35% 10.63% 11.88% 14.02% 14.61% 14.58% 12.41% 16.38% 13.77% 17.04% 13.17%
Profit (Net Income) Margin		 13.94% 9.54% 9.12% 11.09% 13.08% 10.62% 9.48% 12.03% 10.30% 12.71% 9.63%
Tax Burden Percent		 75.97% 77.16% 74.57% 72.57% 86.16% 73.54% 75.69% 73.55% 73.63% 76.85% 72.17%
Interest Burden Percent		 112.21% 116.38% 102.98% 109.02% 103.87% 99.08% 100.97% 99.87% 101.57% 97.07% 101.37%
Effective Tax Rate		 24.03% 22.84% 25.43% 27.43% 13.84% 26.46% 24.31% 26.45% 26.37% 23.15% 27.83%
Return on Invested Capital (ROIC)		 6.54% 4.24% 4.33% 4.99% 6.02% 5.23% 4.67% 6.12% 5.09% 6.91% 5.04%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.85% 4.50% 4.38% 5.19% 6.12% 5.21% 4.69% 6.11% 5.12% 6.81% 5.07%
Return on Net Nonoperating Assets (RNNOA)		 10.94% 6.86% 6.61% 7.56% 9.07% 7.18% 6.27% 7.80% 6.35% 7.84% 5.66%
Return on Equity (ROE)		 17.48% 11.10% 10.93% 12.56% 15.09% 12.41% 10.94% 13.92% 11.44% 14.75% 10.70%
Cash Return on Invested Capital (CROIC)		 1.38% -2.58% 3.76% 1.51% -3.48% -0.51% 0.41% 0.64% 5.36% 11.01% 8.69%
Operating Return on Assets (OROA)		 7.32% 4.65% 5.02% 5.96% 6.06% 6.15% 5.32% 7.23% 5.97% 7.73% 6.02%
Return on Assets (ROA)		 6.24% 4.17% 3.86% 4.72% 5.42% 4.48% 4.07% 5.31% 4.47% 5.76% 4.40%
Return on Common Equity (ROCE)		 17.40% 11.05% 10.89% 12.50% 14.71% 12.17% 10.73% 13.68% 11.04% 14.33% 10.39%
Return on Equity Simple (ROE_SIMPLE)		 19.00% 0.00% 14.54% 12.62% 12.26% 0.00% 12.37% 12.57% 11.58% 0.00% 12.35%
Net Operating Profit after Tax (NOPAT)		 149 94 110 128 158 136 125 165 140 179 132
NOPAT Margin		 12.42% 8.20% 8.86% 10.17% 12.59% 10.72% 9.39% 12.05% 10.14% 13.09% 9.50%
Net Nonoperating Expense Percent (NNEP)		 -0.31% -0.27% -0.05% -0.20% -0.10% 0.02% -0.02% 0.00% -0.04% 0.09% -0.03%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 83.65% 89.37% 88.12% 85.98% 85.39% 85.42% 87.59% 83.62% 86.23% 82.96% 86.83%
Earnings before Interest and Taxes (EBIT)		 196 122 148 176 184 185 165 225 191 232 183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 339 266 300 328 340 343 332 392 364 406 359
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.51 5.93 6.06 6.84 5.20 6.68 7.21 6.38 7.41 6.59 6.06
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 4.14 4.75 5.07 5.92 4.56 6.03 6.44 5.74 6.79 5.79 5.48
Price to Earnings (P/E)		 29.18 33.73 41.97 54.64 42.88 55.55 59.00 51.37 64.64 52.29 49.33
Dividend Yield		 0.92% 0.81% 0.78% 0.67% 0.86% 0.63% 0.58% 0.64% 0.53% 0.61% 0.64%
Earnings Yield		 3.43% 2.96% 2.38% 1.83% 2.33% 1.80% 1.69% 1.95% 1.55% 1.91% 2.03%
Enterprise Value to Invested Capital (EV/IC)		 2.70 2.92 3.03 3.42 2.65 3.41 3.67 3.38 3.90 3.64 3.44
Enterprise Value to Revenue (EV/Rev)		 5.30 5.92 6.25 7.09 5.78 7.19 7.57 6.82 7.78 6.73 6.40
Enterprise Value to EBITDA (EV/EBITDA)		 17.42 20.29 23.19 27.85 22.93 27.54 28.79 25.33 29.11 24.57 23.19
Enterprise Value to EBIT (EV/EBIT)		 27.51 33.51 41.70 53.54 45.00 52.20 54.53 47.01 54.43 45.13 42.46
Enterprise Value to NOPAT (EV/NOPAT)		 35.69 44.49 54.92 71.40 57.84 67.93 70.76 60.93 73.52 60.23 57.26
Enterprise Value to Operating Cash Flow (EV/OCF)		 32.50 38.64 27.44 31.40 25.27 32.36 31.74 29.12 31.51 27.70 27.23
Enterprise Value to Free Cash Flow (EV/FCFF)		 202.63 0.00 81.29 230.83 0.00 0.00 906.91 541.40 72.79 32.26 39.07
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.60 1.52 1.46 1.38 1.38 1.26 1.24 1.18 1.11 1.05 1.00
Long-Term Debt to Equity		 1.28 1.21 1.22 1.31 1.23 1.01 1.01 0.98 0.94 0.88 0.85
Financial Leverage		 1.60 1.52 1.51 1.46 1.48 1.38 1.34 1.28 1.24 1.15 1.12
Leverage Ratio		 3.05 2.98 2.90 2.83 2.86 2.75 2.71 2.62 2.59 2.50 2.45
Compound Leverage Factor		 3.43 3.47 2.98 3.09 2.97 2.73 2.74 2.62 2.63 2.43 2.49
Debt to Total Capital		 61.59% 60.31% 59.31% 58.04% 58.00% 55.76% 55.27% 54.17% 52.71% 51.14% 50.12%
Short-Term Debt to Total Capital		 12.57% 12.17% 9.58% 3.16% 6.48% 10.96% 10.23% 9.21% 8.47% 8.20% 7.92%
Long-Term Debt to Total Capital		 49.02% 48.15% 49.72% 54.87% 51.52% 44.81% 45.04% 44.96% 44.24% 42.93% 42.19%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.17% 0.17% 0.18% 0.17% 1.79% 1.45% 1.43% 1.30% 1.29% 1.22% 1.28%
Common Equity to Total Capital		 38.24% 39.52% 40.51% 41.79% 40.21% 42.79% 43.30% 44.52% 46.00% 47.64% 48.60%
Debt to EBITDA		 3.97 4.19 4.54 4.72 5.02 4.50 4.33 4.06 3.93 3.45 3.38
Net Debt to EBITDA		 3.81 3.99 4.37 4.59 4.68 4.34 4.18 3.93 3.60 3.33 3.25
Long-Term Debt to EBITDA		 3.16 3.34 3.81 4.46 4.46 3.62 3.53 3.37 3.30 2.89 2.84
Debt to NOPAT		 8.14 9.18 10.76 12.10 12.65 11.11 10.65 9.77 9.93 8.45 8.34
Net Debt to NOPAT		 7.81 8.75 10.34 11.76 11.81 10.70 10.29 9.46 9.10 8.17 8.02
Long-Term Debt to NOPAT		 6.48 7.33 9.02 11.44 11.24 8.93 8.68 8.11 8.33 7.10 7.02
Noncontrolling Interest Sharing Ratio		 0.44% 0.44% 0.44% 0.41% 2.52% 1.97% 1.91% 1.71% 3.45% 2.87% 2.86%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -464 -810 -69 -204 -688 -449 -379 -354 146 707 419
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -9.86 -14.83 -1.20 -3.36 -10.95 -7.45 -6.35 -6.17 2.60 12.66 7.91
Operating Cash Flow to Interest Expense		 7.54 5.96 2.62 4.32 6.08 5.34 4.23 4.67 8.52 5.82 4.23
Operating Cash Flow Less CapEx to Interest Expense		 7.54 5.96 2.62 4.32 6.08 5.34 4.23 4.67 8.52 5.82 4.23
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.45 0.44 0.42 0.43 0.41 0.42 0.43 0.44 0.43 0.45 0.46
Fixed Asset Turnover		 0.00 3.40 0.00 0.00 0.00 2.94 0.00 0.00 0.00 2.93 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 9,831 10,011 10,032 10,029 10,677 10,596 10,536 10,548 10,671 10,068 10,249
Invested Capital Turnover		 0.53 0.52 0.49 0.49 0.48 0.49 0.50 0.51 0.50 0.53 0.53
Increase / (Decrease) in Invested Capital		 613 904 179 332 846 585 504 519 -5.70 -528 -287
Enterprise Value (EV)		 26,551 29,251 30,364 34,334 28,310 36,135 38,683 35,641 41,655 36,691 35,280
Market Capitalization		 20,721 23,481 24,629 28,660 22,339 30,290 32,910 29,971 36,361 31,589 30,207
Book Value per Share		 $30.71 $32.31 $33.18 $34.17 $34.98 $36.80 $36.94 $37.99 $39.67 $38.70 $40.16
Tangible Book Value per Share		 ($52.96) ($35.45) ($52.35) ($51.82) ($55.94) ($34.49) ($53.96) ($52.86) ($51.22) ($27.16) ($48.71)
Total Capital		 9,831 10,011 10,032 10,029 10,677 10,596 10,536 10,548 10,671 10,068 10,249
Total Debt		 6,055 6,038 5,949 5,820 6,192 5,909 5,823 5,714 5,624 5,149 5,136
Total Long-Term Debt		 4,819 4,820 4,988 5,503 5,500 4,748 4,745 4,743 4,721 4,323 4,324
Net Debt		 5,813 5,753 5,717 5,656 5,780 5,692 5,622 5,532 5,156 4,979 4,941
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 -18 -15 -3.28 -12 -6.12 1.25 -1.21 0.22 -2.21 5.23 -1.80
Net Nonoperating Obligations (NNO)		 6,055 6,038 5,949 5,820 6,192 5,909 5,823 5,714 5,624 5,149 5,136
Total Depreciation and Amortization (D&A)		 143 145 152 152 157 159 167 167 173 174 176
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.35 $0.88 $0.92 $1.13 $1.32 $1.07 $1.01 $1.32 $1.14 $1.41 $1.07
Adjusted Weighted Average Basic Shares Outstanding		 122.40M 122.40M 122.60M 122.70M 123M 122.90M 123.50M 123.70M 123.90M 123.80M 124.10M
Adjusted Diluted Earnings per Share		 $1.34 $0.88 $0.91 $1.12 $1.31 $1.06 $1.00 $1.31 $1.13 $1.40 $1.06
Adjusted Weighted Average Diluted Shares Outstanding		 123.30M 123.30M 123.50M 123.80M 123.90M 123.90M 124.80M 124.80M 125.20M 124.90M 125.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 122.44M 122.49M 122.64M 122.72M 123.22M 123.96M 123.61M 123.74M 123.95M 124.02M 124.20M
Normalized Net Operating Profit after Tax (NOPAT)		 149 94 110 128 158 136 125 165 140 179 132
Normalized NOPAT Margin		 12.42% 8.20% 8.86% 10.17% 12.59% 10.72% 9.39% 12.05% 10.14% 13.09% 9.50%
Pre Tax Income Margin		 18.35% 12.37% 12.23% 15.28% 15.18% 14.44% 12.53% 16.36% 13.99% 16.54% 13.35%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.16 2.23 2.57 2.90 2.92 3.06 2.76 3.93 3.39 4.16 3.46
NOPAT to Interest Expense		 3.16 1.72 1.91 2.11 2.52 2.25 2.09 2.89 2.50 3.20 2.50
EBIT Less CapEx to Interest Expense		 4.16 2.23 2.57 2.90 2.92 3.06 2.76 3.93 3.39 4.16 3.46
NOPAT Less CapEx to Interest Expense		 3.16 1.72 1.91 2.11 2.52 2.25 2.09 2.89 2.50 3.20 2.50
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 27.05% 27.73% 32.78% 36.64% 37.03% 43.03% 42.19% 40.59% 42.23% 32.57% 32.15%
Augmented Payout Ratio		 27.05% 27.73% 32.78% 36.64% 37.03% 43.03% 42.19% 40.59% 42.23% 32.57% 32.15%

Key Financial Trends

Equifax (NYSE: EFX) has demonstrated stable financial performance over the last four years, with some notable trends and changes that retail investors should consider.

  • Consistent net income growth over the last four years, with Q1 2025 reporting net income attributable to common shareholders at $133.1 million, moderately down from $174 million in Q4 2024 but showing overall growth compared to earlier years.
  • Total revenue has steadily increased year-over-year, with Q1 2025 total revenue at approximately $1.39 billion, up from around $1.32 billion in Q1 2024 and significantly higher than $1.14 billion in Q4 2022.
  • Equifax has maintained a strong common equity base, which grew from about $3.75 billion at Q3 2022 to nearly $5.0 billion at Q1 2025, indicating solid capital structure strength.
  • The company consistently pays dividends, returning about $0.39 per share each quarter, demonstrating commitment to shareholder returns.
  • Long-term debt levels have remained relatively stable around $4.3 to $5.5 billion, with interest expense slightly decreasing in recent quarters, which could reflect favorable refinancing or debt management strategies.
  • Depreciation expense has gradually increased, reaching around $176 million in Q1 2025 from about $142 million in Q4 2022, which may reflect ongoing investments in fixed assets.
  • Goodwill and intangible assets balance has fluctuated but remains elevated, around $6.6 billion and $4.4 billion respectively in Q1 2025, indicative of significant past acquisitions. This requires monitoring for potential impairment risks.
  • Net interest income remains negative, driven by consistent interest expense on long-term debt with no reported interest income, which is typical for a data and analytics company with substantial leverage.
  • Property and liability insurance claims remain a significant expense, increasing to $656.7 million in Q1 2025 from $539.2 million in Q4 2022, putting pressure on operating margins.
  • Other operating expenses have seen some volatility, with a notable $374.9 million in Q1 2025, signaling potential cost pressures or investments in operational capabilities that may impact near-term profitability.

Summary: Equifax continues to show solid revenue growth and maintains strong equity and dividend payments, making it attractive for investors seeking stability and income. However, rising insurance claims and operating expenses, combined with significant goodwill on the balance sheet, suggest caution. Investors should monitor operational efficiency and any changes in the company's leverage or asset impairment risks.

08/02/25 03:11 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Equifax's Financials

When does Equifax's financial year end?

According to the most recent income statement we have on file, Equifax's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Equifax's net income changed over the last 9 years?

Equifax's net income appears to be on an upward trend, with a most recent value of $607.30 million in 2024, rising from $434.80 million in 2015. The previous period was $551.70 million in 2023. Find out what analysts predict for Equifax in the coming months.

How has Equifax's revenue changed over the last 9 years?

Over the last 9 years, Equifax's total revenue changed from $2.60 billion in 2015 to $5.45 billion in 2024, a change of 109.7%.

How much debt does Equifax have?

Equifax's total liabilities were at $6.84 billion at the end of 2024, a 9.9% decrease from 2023, and a 218.0% increase since 2015.

How much cash does Equifax have?

In the past 9 years, Equifax's cash and equivalents has ranged from $93.30 million in 2015 to $1.68 billion in 2020, and is currently $169.90 million as of their latest financial filing in 2024.

How has Equifax's book value per share changed over the last 9 years?

Over the last 9 years, Equifax's book value per share changed from 19.51 in 2015 to 38.70 in 2024, a change of 98.4%.


Related Companies

This page (NYSE:EFX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners
379 passengers walked away from this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsored
Alien rocks potentially worth trillions…
It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...
Porter & Company | Sponsored
Trump’s crypto advisor may have revealed the next big crypto opportunity
While investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...
Weiss Ratings | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
Too busy to trade? Good.
Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...
Timothy Sykes | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Don’t Touch Tesla Stock Without Reading This First
Jeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...
Brownstone Research | Sponsored